PMLBCL
Showing 1 - 6 of 6
CNS Involvement in Primary Mediastinal Large B-Cell Lymphoma
Active, not recruiting
- Primary Mediastinal Large B-cell Lymphoma (PMBCL)
- DISEASE
- (no location specified)
May 4, 2023
Primary Mediastinal Large B-cell Lymphoma With CNS Involvement
Recruiting
- Primary Mediastinal Large B-cell Lymphoma (PMBCL)
-
Milan, ItalyOspedale San Raffaele
Aug 29, 2023
Primary Mediastinal B-cell Lymphoma Trial in Worldwide (observation, 3D-Conformal Radiotherapy (3D-CRT))
Active, not recruiting
- Primary Mediastinal B-cell Lymphoma
- observation
- 3D-Conformal Radiotherapy (3D-CRT)
-
Louisville, Kentucky
- +84 more
Aug 17, 2022
Diffuse Large B Cell Lymphoma, Primary Mediastinal Large B Cell Lymphoma, Large B-cell Lymphoma Trial in Kaohsiung, Taipei
Recruiting
- Diffuse Large B Cell Lymphoma
- +4 more
- CD19-targeted chimeric antigen receptor T-cell
-
Kaohsiung, Taiwan
- +2 more
Oct 25, 2022
Lentiviral-based Gene-edited Immune Cell Therapy
Not yet recruiting
- Diffuse Large B Cell Lymphoma
- +4 more
- Pell's lentiviral-based gene-edited immune cell therapy
-
Kaohsiung, Taiwan
- +2 more
Oct 25, 2022
Primary Mediastinal Large B Cell Lymphoma Trial in Italy (Brentuximab Vedotin)
Completed
- Primary Mediastinal Large B Cell Lymphoma
- Brentuximab Vedotin
-
Alessandria, AL, Italy
- +8 more
Apr 10, 2017